These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2885168)

  • 21. The effect of single bolus dose of esmolol for controlling the tachycardia and hypertension during laryngoscopy and tracheal intubation.
    Yuan L; Chia YY; Jan KT; Chen CS; Wang CH; Haung LH; Kang L
    Acta Anaesthesiol Sin; 1994 Sep; 32(3):147-52. PubMed ID: 7921858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, beta-adrenoceptor pharmacology and toxicology of S-(-)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride, a short acting beta(1)-specific antagonist.
    Jackman GP; Iakovidis D; Nero TL; Anavekar NS; Rezmann-Vitti LA; Louis SN; Mori M; Drummer OH; Louis WJ
    Eur J Med Chem; 2002 Sep; 37(9):731-41. PubMed ID: 12350290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of bolus and continuous infusion of esmolol on hemodynamic response to laryngoscopy, endotracheal intubation and sternotomy in coronary artery bypass graft.
    Efe EM; Bilgin BA; Alanoglu Z; Akbaba M; Denker C
    Braz J Anesthesiol; 2014; 64(4):247-52. PubMed ID: 24998108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group.
    Am Heart J; 1986 Sep; 112(3):498-505. PubMed ID: 2875641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
    van Zwieten PA
    Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esmolol in the treatment of supraventricular tachyarrhythmias.
    Das G; Ferris J
    Can J Cardiol; 1988 May; 4(4):177-80. PubMed ID: 2899451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group.
    Hohnloser SH; Meinertz T; Klingenheben T; Sydow B; Just H
    Am J Cardiol; 1991 Jun; 67(16):1319-23. PubMed ID: 1675036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultra-short-acting beta-adrenergic blockers.
    Frishman WH; Murthy S; Strom JA
    Med Clin North Am; 1988 Mar; 72(2):359-72. PubMed ID: 2894487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esmolol and beta-adrenergic blockade.
    Wolman RL; Fiedler MA
    AANA J; 1991 Dec; 59(6):541-8. PubMed ID: 1686346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of long QT syndrome-induced ventricular tachycardia with esmolol.
    Balcells J; Rodríguez M; Pujol M; Iglesias J
    Pediatr Cardiol; 2004; 25(2):160-2. PubMed ID: 15046104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY; Gorczynski RJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of esmolol and fentanyl in controlling increases in heart rate and blood pressure during endotracheal intubation.
    Gaubatz CL; Wehner RJ
    AANA J; 1991 Feb; 59(1):91-6. PubMed ID: 1672049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta 1-adrenoceptor subtype selective antagonism of esmolol and its major metabolite in vitro and in man. Investigations using tricresylphosphate as red blood cell carboxylesterase inhibitor.
    Jahn P; Eckrich B; Schneidrowski B; Volz-Zang C; Schulte B; Mutschler E; Palm D
    Arzneimittelforschung; 1995 May; 45(5):536-41. PubMed ID: 7612051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications.
    Sand IC; Brody SL; Wrenn KD; Slovis CM
    Am J Emerg Med; 1991 Mar; 9(2):161-3. PubMed ID: 1671639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esmolol blunts postoperative hemodynamic changes after propofol-remifentanil total intravenous fast-track neuroanesthesia for intracranial surgery.
    Bilotta F; Lam AM; Doronzio A; Cuzzone V; Delfini R; Rosa G
    J Clin Anesth; 2008 Sep; 20(6):426-30. PubMed ID: 18929282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol].
    Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G
    Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia.
    Oxorn D; Knox JW; Hill J
    Can J Anaesth; 1990 Mar; 37(2):206-9. PubMed ID: 1968784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of intrathecal esmolol on heat-evoked responses in a postoperative pain model.
    Ono H; Ohtani N; Matoba A; Kido K; Yasui Y; Masaki E
    Am J Ther; 2015; 22(2):111-6. PubMed ID: 23411610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.